These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 678907)

  • 21. Regulatory aspects of parenteral drugs.
    Jennings J
    Bull Parenter Drug Assoc; 1972; 26(2):53-7. PubMed ID: 5012204
    [No Abstract]   [Full Text] [Related]  

  • 22. [Quality control of infusion fluids. II. Quantitative analysis of infusion fluids].
    van den Bemd AA
    Pharm Weekbl; 1970 Jan; 105(4):97-9. PubMed ID: 5417757
    [No Abstract]   [Full Text] [Related]  

  • 23. Validation: why, what, when, how much.
    Gold DH
    PDA J Pharm Sci Technol; 1996; 50(1):55-60. PubMed ID: 8846060
    [No Abstract]   [Full Text] [Related]  

  • 24. Contaminated drip fluids.
    Maddocks AC; Raine G
    Br Med J; 1972 Apr; 2(5807):231. PubMed ID: 5022740
    [No Abstract]   [Full Text] [Related]  

  • 25. Pyrogens in small-volume parenterals prepared in hospital pharmacy.
    Lacasa C; Vega FA
    J Parenter Sci Technol; 1989; 43(5):246-9. PubMed ID: 2809933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Particles in intravenous fluids.
    Mead WB
    N Engl J Med; 1972 Nov; 287(22):1152. PubMed ID: 4678074
    [No Abstract]   [Full Text] [Related]  

  • 27. Steam sterilization-in-place technology.
    Agalloco J
    J Parenter Sci Technol; 1990; 44(5):253-6. PubMed ID: 2250201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parameters governing steam sterilization of deadlegs.
    Young JH; Ferko BL; Gaber RP
    J Pharm Sci Technol; 1994; 48(3):140-7. PubMed ID: 8069515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on microbial contamination of infusion fluids arising from drug additions and administration.
    Ernerot L; Thorén S; Sandell E
    Acta Pharm Suec; 1973 May; 10(2):141-6. PubMed ID: 4728099
    [No Abstract]   [Full Text] [Related]  

  • 30. Contaminated drip fluids.
    Phillips I; Eykyn S
    Br Med J; 1972 Mar; 1(5802):746. PubMed ID: 5015334
    [No Abstract]   [Full Text] [Related]  

  • 31. Contaminated infusion fluids.
    Br Med J; 1972 Jul; 3(5820):190-1. PubMed ID: 5040702
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on microbiological contamination of in-use IV-fluids.
    Stjernström G; Gunnarsson B; Wikner H
    Acta Pharm Suec; 1978; 15(3):169-74. PubMed ID: 362822
    [No Abstract]   [Full Text] [Related]  

  • 33. Hygienic standard of parenteral solutions.
    Winding O
    Ugeskr Laeger; 1977 Dec; 139(49):2940-4. PubMed ID: 595183
    [No Abstract]   [Full Text] [Related]  

  • 34. Design control and validation of a facility for sterile clinical trial preparations.
    Staines L
    J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
    [No Abstract]   [Full Text] [Related]  

  • 35. Structure of products prepared by freeze-drying solutions containing organic solvents.
    Seager H; Taskis CB; Syrop M; Lee TJ
    J Parenter Sci Technol; 1985; 39(4):161-79. PubMed ID: 4032158
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter: Addition of drugs to intravenous fluids.
    Lancet; 1976 Apr; 1(7964):858. PubMed ID: 56671
    [No Abstract]   [Full Text] [Related]  

  • 37. Problems with intravenous solutions.
    Gladhart WR; Simpson TR
    Am J Hosp Pharm; 1972 Nov; 29(11):918. PubMed ID: 4654997
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reliability of infusion systems and equipment].
    Schmitz JE; Schreiber MN
    Klin Anasthesiol Intensivther; 1990; 38():274-88. PubMed ID: 2232611
    [No Abstract]   [Full Text] [Related]  

  • 39. Application of the Limulus amebocyte lysate assay in outbreaks of pyrogenic reactions associated with parenteral fluids and medical devices.
    Highsmith AK; Anderson RL; Allen JR
    Prog Clin Biol Res; 1982; 93():287-99. PubMed ID: 7122595
    [No Abstract]   [Full Text] [Related]  

  • 40. In-use physicochemical and microbiological stability of biological parenteral products.
    Ricci MS; Frazier M; Moore J; Cromwell M; Galush WJ; Patel AR; Adler M; Altenburger U; Grauschopf U; Goldbach P; Fast JL; Krämer I; Mahler HC
    Am J Health Syst Pharm; 2015 Mar; 72(5):396-407. PubMed ID: 25694415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.